Phospholipase A2 (PLA2) activities in cytosolic, mitochondrial, and microsomal fractions of rat kidneys were characterized under control conditions, after ischemia, and subsequent to ischemia and reperfusion. Two forms of PLA2 activity were present in the cytosolic fraction: a high molecular weight form, active against phosphatidyicholine (PC), and phosphatidylethanolamine (PE), which upon purification has a molecular mass of 110 kD', and a smaller form (M, 14 kD), active against PE.
Introduction
Phospholipase A2 (PLA2)' has been proposed to play an important role in cell injury associated with ischemia (1) . This enzyme acts on membrane phospholipids at the sn-2 position to 1. Abbreviations used in thispaper: AA, arachidonic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PLA2, phospholipase A2. generate lysophospholipids and free fatty acids. The resultant PLA2-induced changes in phospholipid integrity and the toxic actions offree fatty acids and lysophospholipids may be critical to the altered plasma membrane and mitochondrial permeability properties and bioenergetic capacity associated with ischemia and reperfusion. The lipid peroxidation that occurs with ischemia and reperfusion may result in enhanced susceptibility of cellular membranes to PLA2 (2, 3) . The potential importance of PLA2 activity in ischemic cell injury is supported by the protection that PLA2 inhibitors afford against phospholipid degradation and the associated reduction in infarct size after coronary artery occlusion in rats (4) and also the partial preservation ofthe mucosal permeability barrier in the ischemic and reperfused intestine, attributed to PLA2 inhibition (5) .
The mitochondria represent particularly important sites of PLA2 action resulting in mitochondrial dysfunction which may play an important role in the pathophysiology ofischemic injury (6, 7) . Changes in mitochondrial membrane integrity could markedly impair ATP generation and hence reduce the energy currency required for recovery processes (8) . Our previously reported data led us to conclude that PLA2 activation, consequent to calcium and reactive oxygen species exposure during reoxygenation, played an important role in electron transport chain damage localized to NADH coenzyme Q reductase, decreased F,-ATPase activity, decreased ADP-ATP translocase activity, and increased mitochondrial membrane permeability to H+ ions (3, 6) . Exogenous PLA2 treatment of hypoxic proximal tubules results in severe cellular injury and significant decreases in uncoupled respiratory rates of the tubules, reflective of electron transport chain damage (9) .
Previous studies in kidney (10) , brain (11), and heart (12) have implicated PLA2 activation in the mediation ofischemiarelated tissue injury on the basis of measured increases in free fatty acids in ischemic and postischemic tissue. The increases in unsaturated fatty acids are generally greater than those of saturated fatty acids, providing further evidence for the activation of PLA2, since the sn-2 position of phospholipids is enriched with unsaturated fatty acids. Free fatty acid release, however, is not a reliable measure of PLA2 activity since other enzymes can release fatty acids (12, 13) and activity of reacylation enzymes may contribute in an important way to the steady-state levels of free fatty acids. In only a few studies has PLA2 activity been measured directly. In fact, in a study in the heart (14) the cytosolic PLA2 activity was measured directly and found to be decreased, leading the authors and others (15) to question whether PLA2 plays an important role in ischemic injury.
In the present study we partially characterized the kidney cytosolic, mitochondrial, and microsomal PLA2 activities and measured PLA2 activity directly in cytosolic, mitochondrial, and without reperfusion. Our Animal preparation. Male Sprague-Dawley rats weighing 200-250 g were anesthetized with sodium pentobarbital (Pentothal, 65 mg/kg body weight) administered intraperitoneally and the animal was placed on a heated operating table. After a tracheostomy was performed, the right jugular vein was exposed and cannulated for the administration of 0.9% NaCl at 0.02 ml/min. The left kidney was exposed through a midline laparotomy incision. The left renal pedicle was isolated and occluded, for the time indicated, with a microaneurysm vascular clamp (Roboz Surgical Instrument Co., Inc., Washington, DC). The contralateral kidney served as a control. In addition, sham-operated animals were used as controls. In these sham animals the left renal pedicle was isolated but not clamped.
In some experiments both kidneys were removed immediately at the end ofthe ischemic period. In other animals the vascular clamp was released after 45 min ofischemia and kidneys were removed after I h of reperfusion. In order to control for possible effects of unilateral kidney ischemia on the contralateral kidney, control kidneys were also taken from animals not previously operated upon.
Rats used in this study were maintained in accordance with the guidelines of the Committee on Animals of the Harvard Medical School and the Massachusetts General Hospital, and those prepared by the Committee on Care and use of Laboratory Animals ofthe Institute of Laboratory Animal Resources, National Research Council.
Subcellularfractionation and extraction ofPLA2. Excised kidneys were rinsed in ice-cold buffer and immediately minced with scissors. Pieces were transferred into homogenizing buffer, containing 50 mM Tris-HCl (pH 7.5), 250 mM sucrose, 1 mM EDTA, 1 mM EGTA, and phenylmethylsulfonyl chloride (0.1 mM), aprotinin (1,000 kallikreininactivating units/ml), leupeptin (20 uM) , and pepstatin (20 MM) as protease inhibitors. Kidneys were homogenized with a homogenizer (Polytron, Brinkmann Instruments Co., Kriens-Luzern, Switzerland) in 10 ml of buffer for 90 s. The homogenate was then successively centrifuged for 10 min at 900 g(to sediment cell debris and nuclear and plasma membranes), followed by 20 min at 9,000 g (to sediment mitochondria) and 60 min at 100,000 g (to obtain microsomes) at 4°C (16) . The high-speed supernatant represents the cytosolic fraction.
Various solutions and detergents were tested for their ability to extract PLA2 activity from the kidney membrane fractions: the original homogenizing buffer; 50 mM Tris buffer with and without 0.3% lithium dodecyl sulfate, 5 mM cholic acid, 1% octyl glucoside, 1 M KCl, or 1 M NaCl. An extraction buffer consisting of50 mM Tris-HCl buffer, 1 mM EGTA, 1 mM EDTA, and 1 M KCl resulted in the most efficient extraction of PLA2 activity from mitochondrial and microsomal membrane fractions. Therefore the pellets were resuspended in this buffer by passing them through a 2-ml syringe with a 2 1-gauge needle at least 15-20 times. After 1 h of incubation at 40C the resuspended pellets were centrifuged for 60 min at 100,000 g. Greater than 90% of total mitochondrial or microsomal KCl-suspension activity was recovered in the supernatant fraction after centrifugation. PLA2 assay. PLA2 activity was measured as previously described with some modifications (17 FPLCfractionation. 250-400-zA samples of each subcellular fraction were loaded onto a 24-ml gel filtration column (Superose 12, Pharmacia LKB Biotechnology Inc., Piscataway, NJ), previously equilibrated with 50 mM Tris, 0.15 M NaCl, 1 mM EDTA, and 1 mM EGTA buffer at 40C. Samples were run in this buffer at a flow rate of 0.5 ml/min. The column was calibrated using, as standards, blue dextran (M, = 2,000 kD), bovine serum albumin (66 kD), ovalbumin (45 kD), porcine pancreas PLA2 (13.5 kD), horse heart cytochrome c oxidase (12.4 kD), and vitamin B12 (1.35 kD). l-ml fractions were collected and assayed for PLA2 activity. The protein concentration ofeach fraction was monitored by absorbance at 280 nm.
PLA2 activity pH dependency. Samples of the cytosolic and mitochondrial fractions were diluted with buffers of different pH (pH 5.0-11.0). The actual pH and PLA2 activity of each sample were determined in the presence ofCa2+. Tris-HCl buffer was employed to make up solutions of pH 7.5 or less and glycine/NaOH buffer was used for pH 8.0 and above. All the samples were matched for protein.
PLA2 activity Ca2' dependency. Extracts were diluted 1:8 with buffers consisting of NaCl 140 mM, Hepes 25 mM, and varying amounts ofCaCl2, with or without EGTA, 1 mM at pH 7.5. Enzymatic activity was determined after an aliquot of the mixture was taken to measure the free calcium concentration. Enzymatic activity and free calcium concentration were measured at 37°C. For Ca2+ concentrations below 1 ,uM, Ca2+ concentration was determined using the dual wavelength fluorescence characteristics offura-2 free acid, using a dual wavelength spectrofluorometer (Deltascan Spectrofluorometer, Photon Technology Inc., Princeton, NJ). For concentrations > 1 MM the free Ca2+ concentration was determined with a Ca2+-selective electrode, which we constructed and calibrated as previously described ( 18 (Fig. 1 A) . This is similar to the previously described peak of cytosolic activity (17) which we have subsequently found to have an actual molecular mass ofapproximately 1 10 kD as determined by SDS-PAGE (19) . When PE was used as a substrate there were two peaks of activity ( Fig. 1 B) Figure 4 . Cytosolic, mitochondrial, and microsomal PLA2 (A and B) specific and (C and D) total activities in control (contralateral kidney) extracts and extracts of kidneys after 45 min of ischemia without reperfusion. There were significant reductions in cytosolic PLA2 specific activity when either (A) PC or (B) PE were used as substrates. There was greater specific activity against PE than PC in the mitochondrial and microsomal extracts. Ischemia resulted in increased mitochondrial PLA2 specific activity against PC and PE and increased microsomal activity against PE. Cytosolic total PLA2 activity was significantly decreased when PC was used as substrate (C) . By contrast, mitochondrial and microsomal total PLA2 activities were enhanced with ischemia, whether PLA2 activity was measured using (C) PC or (D) PE as substrate. *P < 0.05; **P < 0.01 compared with controls.
The microsomal extract contained a single peak ofactivity. This PLA2 activity eluted from the column at exactly the same position as the mitochondrial PLA2 activity against both PC and PE (Fig. 3) .
When PLA2 activities in control kidney subcellular fractions were compared, the highest PLA2 specific (Fig. 4 A) and total activities (Fig. 4 C) against PC were observed in the cytosolic fraction. While the specific PLA2 activity of the cytosol was approximately the same whether PC or PE were used as substrates, the mitochondrial and microsomal fractions had greater specific activities against PE (Fig. 4, A and B) . Subcellular distribution ofPLA2 activity in the kidney after ischemia without reflow. To determine whether PLA2 activity in the various subcellular fractions was altered with ischemia, the activity of mitochondria, microsomes, and the 100,000-g supernatant (cytosol) were assayed after varying periods of ischemia without reperfusion. To establish that there was no differential extraction between control and ischemic kidneys, owing to ischemia-related membrane damage, cytosolic activity was determined as a fraction of total (cytosolic + mitochondrial + microsomal) activity in three initial experiments using PC as substrate. The fraction oftotal activity in the high speed supernatant was 78±4% in controls and 73±7% in ischemic kidneys.
Ischemia without reperfusion resulted in a rapid decrease of cytosolic PLA2 specific activity when either PC or PE were used as substrates (Fig. 4, A and B) . Decreases of both specific and total activities against PC were seen as soon as 5 min after placing the clamp (Fig. 5) . Contralateral control kidney soluble PLA2 activity was equal to that of kidneys in sham-operated animals (data not shown). Cytosolic PLA2 activity was determined in the presence and absence ofcalcium (either no added calcium or 4 mM Ca2" in the reaction buffer containing 0.75 mM EGTA and 0.75 mM EDTA. As depicted in Fig. 5 the enzymatic activity against PC was Ca2' dependent. The decreased cytosolic enzymatic activity, with ischemia alone, was observed when the assay was performed in the presence or absence of Ca2".
In contrast to the decrease in cytosolic PLA2 specific activity, 45 min of ischemia resulted in a significant increase of specific activity in the mitochondrial fraction when activity was determined against PC (Fig. 4 A) and in both mitochondrial and microsomal fractions when PE, the preferred substrate for PLA2 in these fractions, was used (Fig. 4 B) . Whereas total cytosolic PLA2 activity was decreased when PC was used as substrate, total activity of both mitochondrial and microsomal fractions were increased in the ischemic kidney whether PE or PC was the substrate (Fig. 4, C and D peak, eluting with an apparent molecular mass of -2-3 kD, was not present in the preischemic samples. Mitochondrial ischemia/reperfusion samples, when fractionated by Superose 12 gel filtration chromatography, had two peaks of activity against PC and PE (fractions 17 and 21) (Fig.  8) , whereas only one peak (fraction 17) was present in control mitochondrial samples (Fig. 2 B) . Microsomal fractionation resulted in a pattern of PLA2 activity similar to that of the mitochondria (data not shown).
Cytosolic and mitochondrial PLA2 pH dependency. In both cytosolic and mitochondrial fractions from control kidneys, the PLA2 activities had pH optima in the range 8.5-9.5, whether PC (Fig. 9) or PE (data not shown) was used as substrate. Ischemia and reperfusion did not alter the pH optima of cytosolic (data not shown) or mitochondrial PLA2 activity (Fig.  9 B) .
Calcium dependency ofcytosolic and mitochondrialforms ofkidney PLA2. PLA2 activity in each ofthe cellular fractions is Ca2' dependent. As shown in Fig. 5 , cytosolic activity against PC and PE is markedly enhanced with calcium. The specific Ca2+ concentration dependency of cytosolic and mitochondrial PLA2 activity is shown in Fig. 10 . This calcium dependency of cytosolic and mitochondrial fractions was unaffected by ischemia alone or ischemia and reperfusion (data not shown). Note that cytosolic PLA2 activity was enhanced when Ca2+ concentration was increased from 100 nM, a value representing baseline cytosolic Ca2' concentration in renal epithelial cells (20) , to 200-300 nM, values well within the range reached in response to both physiological and pathophysiological stimuli (1). By contrast, mitochondrial PLA2 activity was not in- Discussion to extract activity. This difference was observed even though cholate extraction resulted in recovery of only 36.0±8.8% (n = 6) of KCl-extracted activity.
PLA2 activity after 45 min ofischemia and I h ofreflow. To determine whether PLA2 activity was altered after reperfusion ofthe ischemic kidney, cytosolic and mitochondrial PLA2activ-ities were measured after 45 min ofischemia followed by 1 h of reperfusion. As demonstrated in Fig. 6 , there were significant increases of cytosolic PLA2 specific and total activities against both PE and PC with ischemia and reperfusion. Mitochondrial specific activity against PC was increased. Mitochondrial and microsomal specific and total activities against PE were increased with ischemia and reperfusion.
Characterization of the cytosolic and mitochondrial PLA2 activity after reflow. To further characterize PLA2 activation associated with ischemia and reflow, cytosolic and mitochondrial samples were matched for protein and fractionated by Superose 12 gel filtration chromatography. PLA2 activity measured against PC in ischemic/reperfusion cytosolic fractions migrated as a single peak (Fig. 7 A) at the same position as the peak of activity in control kidney cytosol (Fig. 1 A) . When PE was used as substrate, three peaks of activity were seen, eluting at fractions 13, 17, and 21 (Fig. 7 B) . The first two peaks correspond to the peaks of activity observed in control kidney cytosolic fractions when PE is used as substrate (Fig. 1 B) . The third Although a considerable amount is known about secretory forms of PLA2 the intracellular forms are less well characterized. Our results indicate the presence of two distinct forms of PLA2 in the cytosolic fraction ofthe kidney. The large molecular weight form has been previously characterized and recently purified in our laboratories (17, 19) . This form is active against PE and PC. In addition to this form, our data indicate the presence of an additional smaller molecular weight form that has activity against PE but not PC. It is unlikely that this smaller form is a contaminant from the mitochondria or microsomes since the smaller molecular weight forms extracted from mitochondria and microsomes have activity against both PC and PE.
In both mitochondrial and microsomal fractions from control kidneys there were single peaks of activity with apparent molecular mass of 14 kD. This size, together with the alkaline pH optimum and the Ca2' dependency, are characteristics similar to those of previously described mitochondrial and microsomal forms from other tissues, such as rat liver (22, 23) and spleen (24) . Membrane Figure 6 . Cytosolic, mitochondrial, and microsomal PLA2 (A and B) specific and (C and D) total activities in control (contralateral kidney) extracts and extracts of kidneys removed after 45 min of ischemia and 1 h of reperfusion. Cytosolic and mitochondrial PLA2 specific activities were increased in the postischemic kidney extracts when PC was the substrate (A). Cytosolic, mitochondrial, and microsomal extract specific PLA2 activities were increased when PE was the substrate (B). Total PLA2 activity was enhanced with ischemia in the cytosolic fraction when PC was the substrate (C) and in cytosolic, mitochondrial, and microsomal fractions when PE was the substrate (D). *P < 0.05 compared with controls.
The activities from cytosol, mitochondria, and microsomes
were Ca2" dependent with alkaline pH optima. When the detailed Ca2" concentration dependency of cytosolic and mitochondrial PLA2 activities was compared, an important difference was noted. The cytosolic form of the enzyme was activated at Ca2+ concentrations at least one order of magnitude lower than those necessary to enhance mitochondrial PLA2 activity. The [Ca2+] sensitivity characteristics are consistent with important physiological and pathophysiological roles for both cytosolic and mitochondrial enzymes in the intact cell.
The similarities between the [Ca2+1 sensitivity of the cytosolic form and the [Ca2+] sensitivity of prostaglandin production in mesangial cells which we previously reported (26), together with the fact that the major form ofPLA2 activity in the mesangial cell and kidney cytosolic extracts is identical (17) increases with ischemia and reperfusion to levels at which mitochondrial PLA2 enzymatic activity is enhanced. Phospholipid degradation is believed to contribute to tissue injury associated with ischemia in the kidney (32), brain (1 1), heart (4, 33), intestine (34) , and liver (35) . This observation, together with experiments demonstrating arachidonic acid release or prostaglandin synthesis, is consistent with the conclusion that phospholipase A2 may be an important contributor to ischemic cell damage. Other enzymatic processes, however, besides PLA2 activity directed against phospholipids, can result in elevated tissue free fatty acid levels (13) . For example, phospholipase C, followed by diacylglycerol lipase, or followed by diacylglycerol kinase and phosphatidic acid-specific PLA2, can result in increased free fatty acid levels, as can increased triglyceride lipase activity. PLA, followed by lysophospholipase, can also generate increased free arachidonate levels. Plasmalogenase and lysophospholipase can release arachidonate from plasmalogens. Furthermore, inhibition of reacylation mechanisms can also enhance tissue levels of free fatty acids. For example, the activity of lysophosphatidylcholine acyltransferase has been reported to be decreased in ischemic pig myocardium (36) . PLA2 enzymatic activity has seldom been directly measured during ischemia or after reperfusion. It has been generally assumed that increases in cytosolic Ca>2 concentration brought about by ischemia will activate a calcium-dependent PLA2 enzyme. There are many forms of PLA2, however, and some ofthese forms in nonrenal tissues are not Ca> dependent (37 Direct experimental evidence for the activation of phospholipases with ischemia was found in extracts of gerbil brain tissue taken after 1 min ofbilateral carotid occlusion (38) ; however, PLA2 activity returned to baseline levels by 5 min of ischemia and there was no correlation between PLA2 activity and the tissue levels of free fatty acid during and after ischemia. PLA2 activity was increased in homogenates of small intestinal mucosal cells after ischemia and reperfusion (34) . Kawaguchi and Yasuda (39) reported increases of mitochondrial and microsomal PLA2 activity in hypoxic myocardium. This PLA2 activity had a substrate specificity for PE, but the mechanism of activation was not clarified and the enzymatic activity was not further characterized. By contrast, in the ischemic area of the isolated rat heart homogenate and mitochondrial PLA2 enzymatic activity was found to be decreased 20 min after coronary artery ligation (14) .
In the present study PLA2 activity against PE and PC in the cytosol decreased rapidly after ischemia if the kidney was not reperfused. Our data do not provide an explanation of decreased cytosolic activity after ischemia without reperfusion. Endogenous inhibitors of PLA2 have been found in other systems (40) and it is possible that inhibitors, such as unsaturated fatty acids (41) , may be present in the cytosolic fraction after 45 min of ischemia. Bentham and colleagues (14) attributed the decrease in PLA2 activity seen after 20 min of ischemia in the heart to the presence of lysophosphatidylcholine and palmitoylcarnitine, two (15) . PLA2 may be regulated via phosphorylation by protein kinase C as previously suggested (17, 26) . There is evidence that protein kinase C is activated with ischemia (46) . There is also evidence for enhanced Ca2+-phosphatidylserineindependent kinase activity with ischemia (47) . It is, therefore, possible that phosphorylation of the enzyme can occur after ischemia and reperfusion, resulting in enhanced activity. It is also possible that the decreased cytosolic PLA2 activity that we found after ischemia without reoxygenation may be due to dephosphorylation of PLA2. Alternatively, PLA2 could be tightly associated with regulatory proteins. Protein kinase C has been suggested to phosphorylate proteins which inhibit PLA2 by binding to the phospholipid substrate (48) . Ischemia and reperfusion may result in modifications of these proteins and hence alter PLA2 activity in this manner.
In conclusion, we have demonstrated that different forms of PLA2 are prevalent in the cytosolic and membrane (mitochondrial and microsomal) compartments of the rat kidney. These forms differ markedly in apparent molecular weight as indicated by migration patterns by gel filtration chromatography. The [Ca2+] sensitivity of both cytosolic and mitochondrial PLA2 activities indicate that the enzymes are likely regulated by Ca2+ in vivo. Ischemia without reperfusion results in increased PLA2 activity in mitochondrial and microsomal fractions. After ischemia and reperfusion, cytosolic, mitochondrial, and microsomal PLA2 activities were enhanced and a new form of enzymatic activity was present in the mitochondrial fraction. These stable modifications ofenzymatic activity cannot be explained by changes in [Ca2+] and suggest other regulatory influences. Enhanced PLA2 activity may play an important role in the mediation ofcellular injury after an ischemic insult.
